Status:

TERMINATED

Application of AS101 for the Treatment of Thrombocytopenia in Solid Tumor Patients

Lead Sponsor:

BioMAS Ltd

Conditions:

Chemotherapy Induced Thrombocytopenia

Eligibility:

All Genders

18+ years

Phase:

PHASE2

Brief Summary

Chemotherapy Induced Thrombocytopenia is a common side-effect of bone marrow suppression as a result of a chemotherapy treatment. AS101 is a tellurium based small compound with immunomodulating charac...

Eligibility Criteria

Inclusion

  • Age ≥ 18
  • Appropriate histology of solid tumors.
  • Platelet counts \< 70,000/μl.
  • Performance Status (PS) of 0-2
  • Adequate renal function: Serum creatinine ≤1.5 mg/dL
  • Adequate liver function: Serum (total) bilirubin ≤ 1.5 ULN. AST, ALT ≤ 2.5 x ULN in patients without liver metastases, ≤ 5 x ULN in patients with liver metastases. Albumin ≥ 2.5 g/dL (Only for patients who will receive AS101).
  • INR ≤ 1.5 and PTT ≤ 1.5 x ULN (Only for patients who will receive AS101).

Exclusion

  • Patients unable to provide fully informed consent.
  • Women who are pregnant or breast feeding.
  • The patient is participating in another trial of an investigational drug or has done so within 28 days prior to the pre-treatment visit.
  • The patient has congestive heart failure-New York Heart Association (CHF-NYHA) grade II or higher, and/or myocardial infarction within the last 12 months, or any cardiac disorder which in the opinion of the Investigator would put the patient at risk.
  • The patient has a history of chronic alcohol or drug abuse within the last 5 years.
  • The patient has any other clinically significant medical condition, psychiatric condition or laboratory abnormality which would, in the judgment of the Investigator, interfere with the patient's ability to participate in the trial.

Key Trial Info

Start Date :

August 1 2009

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

August 1 2010

Estimated Enrollment :

40 Patients enrolled

Trial Details

Trial ID

NCT00926354

Start Date

August 1 2009

End Date

August 1 2010

Last Update

June 21 2011

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Meir Medical Center

Kfar Saba, Israel

Application of AS101 for the Treatment of Thrombocytopenia in Solid Tumor Patients | DecenTrialz